Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Magnesium bisglycinate

Magnesium Bisglycinate Chelate · also known as Magnesium glycinate, Magnesium bisglycinate, Chelated Magnesium

Magnesium bisglycinate is an organic chelate of magnesium and is usually well tolerated. Magnesium clearly blocks NMDA channels at the cellular level, but there is no direct evidence that ordinary supplement doses reach an effect of that strength in humans.

Typical dose: Usually 200–400 mg/day of elemental magnesium, often taken after dinner or at bedtime. In the US, the adult upper limit for magnesium from supplements and medicines is usually 350 mg/day, so 400 mg/day is above it.
Absorption and forms: Magnesium bisglycinate is relatively stable. In a 1994 study of patients with intestinal resection, the average absorption of two magnesium preparations was similar. There is therefore no basis for saying it absorbs several times better than magnesium oxide, nor that it never causes diarrhea.

Clinical uses and human evidence

Sleep quality

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Schuster 2025 · Nat Sci Sleep · RCT · n=155 — Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial

High blood pressure

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Argeros 2025 · Hypertension · Meta-analysis · n=2709 — Magnesium Supplementation and Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Migraine prevention

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Peikert 1996 · Cephalalgia · RCT · n=81 — Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study
  2. Pfaffenrath 1996 · Cephalalgia · RCT · n=69 — Magnesium in the prophylaxis of migraine--a double-blind placebo-controlled study

All-cause mortality risk

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Bressendorff 2023 · J Am Soc Nephrol · RCT · n=148 — The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD)
  2. Sakaguchi 2019 · J Am Soc Nephrol · RCT · n=125 — A Randomized Trial of Magnesium Oxide and Oral Carbon Adsorbent for Coronary Artery Calcification in Predialysis CKD

Heart attack, stroke and other cardiovascular events

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Galløe 1993 · BMJ · RCT · n=468 — Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction
  2. Bressendorff 2023 · J Am Soc Nephrol · RCT · n=148 — The Effect of Magnesium Supplementation on Vascular Calcification in CKD: A Randomized Clinical Trial (MAGiCAL-CKD)

Muscle cramps

No benefitGrade B · Moderate evidence
Studies (1)
  1. Garrison 2020 · Cochrane Database Syst Rev · Meta-analysis · n=735 — Magnesium for skeletal muscle cramps

Mechanisms of action

GABA and glutamate balance (inhibitory and excitatory tone)

★★☆☆☆Mechanism evidence: grade DPrimary target

Magnesium blocks NMDA channels in a voltage-dependent way, and this cellular effect is well established. However, there is no human evidence on whether oral magnesium bisglycinate raises free magnesium in the brain and strengthens that block. Glycine does not directly activate GABA receptors. It is also a co-agonist at NMDA receptors.

References (2)
  1. Nowak et al. 1984 · Cultured mouse central neurons: magnesium ions produced a voltage-dependent block of NMDA-related channels
  2. Human research gap · No reliable human study has directly shown that routine oral magnesium bisglycinate strengthens NMDA channel block in the central nervous system

Safety and drug interactions

People with severe, advanced kidney failure (very low creatinine clearance) need to limit magnesium from supplements and medicines to avoid hypermagnesemia. Most people tolerate it well. Magnesium can reduce the absorption of drugs such as tetracyclines and quinolones, so space the doses apart as advised for each drug.

With Levothyroxine Note

Euthyrox, Letrox (levothyroxine)

Magnesium reduces the absorption of levothyroxine, so the two should be taken at least 4 hours apart.

Related lab tests

Kidney function tests Test before supplementing

Applies only to people with known or suspected reduced kidney function: magnesium is cleared mainly by the kidneys and can build up when they work poorly, so check kidney function before starting. Healthy people do not need this test.

Open in the interactive app ›